Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Kinase inhibitors

An allosteric add-on

Nature Chemical Biology volume 10, pages 796–797 (2014)Cite this article

Subjects

Development of highly specific kinase inhibitors has been a long-standing challenge in chemical biology. The structural and mechanistic characterization of an Erk1/2 kinase inhibitor provides new strategies to develop specific kinase inhibitors by targeting a binding pocket adjacent to the ATP binding site.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Comparison of binding modes for small-molecule protein kinase inhibitors.

Debbie Maizels/Nature Publishing Group

References

  1. Jemal, A. et al. CA Cancer J. Clin. 57, 43–66 (2007).

    Article  PubMed  Google Scholar 

  2. Chaikuad, A. et al. Nat. Chem. Biol. 10.1038/nchembio.1629 (7 September 2014).

  3. Morris, E.J. et al. Cancer Discov. 3, 742–750 (2013).

    Article  CAS  PubMed  Google Scholar 

  4. Zhang, J., Yang, P.L. & Gray, N.S. Nat. Rev. Cancer 9, 28–39 (2009).

    Article  PubMed  Google Scholar 

  5. Huse, M. & Kuriyan, J. Cell 109, 275–282 (2002).

    CAS  PubMed  Google Scholar 

  6. Nussinov, R. & Tsai, C.J. Cell 153, 293–305 (2013).

    Article  CAS  PubMed  Google Scholar 

  7. Ohren, J.F. et al. Nat. Struct. Mol. Biol. 11, 1192–1197 (2004).

    Article  CAS  PubMed  Google Scholar 

  8. Regan, J. et al. Bioorg. Med. Chem. Lett. 13, 3101–3104 (2003).

    Article  CAS  PubMed  Google Scholar 

  9. Shan, Y. et al. Proc. Natl. Acad. Sci. USA 106, 139–144 (2009).

    Article  CAS  PubMed  Google Scholar 

  10. Lu, H. & Tonge, P.J. Curr. Opin. Chem. Biol. 14, 467–474 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zachariah H. Foda and Markus A. Seeliger are in the Department of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, New York, USA.,

    Zachariah H Foda & Markus A Seeliger

Authors
  1. Zachariah H Foda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Markus A Seeliger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Markus A Seeliger.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Foda, Z., Seeliger, M. An allosteric add-on. Nat Chem Biol 10, 796–797 (2014). https://doi.org/10.1038/nchembio.1630

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio.1630

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing